Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Net Income 2018–2025
Black Diamond Therapeutics, Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Black Diamond Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -9.0 M, a 115.98% decrease year-over-year.
- Black Diamond Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was 28.4 M.
- Black Diamond Therapeutics, Inc. annual net income for 2025 was 22.4 M, a 132.10% decrease from 2024.
- Black Diamond Therapeutics, Inc. annual net income for 2024 was -69.7 M, a 3.60% increase from 2020.
- Black Diamond Therapeutics, Inc. annual net income for 2020 was -67.3 M, a 90.75% increase from 2019.
- Black Diamond Therapeutics, Inc. annual net income for 2019 was -35.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Black Diamond Therapeutics, Inc. Net Income — FAQ
Black Diamond Therapeutics, Inc. (BDTX) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Black Diamond Therapeutics, Inc.'s net income?
Black Diamond Therapeutics, Inc. (BDTX) reported net income of $22M for fiscal 2025.
Where can I see BDTX's net income history?
The chart and table above show Black Diamond Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.